Fulcrum Therapeutics, Inc.
FULC
Revenue
0.00
0.000.00%
-Assets
366.28M
▲151.43M▲70.48%
3 Months ChangeLiabilities
17.28M
▲792.00k▲4.80%
3 Months ChangeFree Cash Flow
-15.26M
▲10.06M▲39.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-24
Form 8-K
ID: 0001193125-26-065190
2026-01-12
Form 8-K
ID: 0001193125-26-009845
2025-12-11
Form 8-K
ID: 0001193125-25-314728
2025-12-08
Form 8-K
ID: 0001193125-25-310509
2025-10-29
Form 10-Q
ID: 0001193125-25-254633
2025-10-29
Form 8-K
ID: 0001193125-25-254619
2025-08-28
Form 8-K
ID: 0001193125-25-190746
2025-07-29
Form 10-Q
ID: 0000950170-25-099407
2025-07-29
Form 8-K
ID: 0000950170-25-099404
2025-06-27
Form 8-K
ID: 0001193125-25-151276